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IL-18Rα-deficient CD4+ T cells induce intestinal
inflammation in the CD45RBhi transfer model
of colitis despite impaired innate responsiveness
Petra Holmkvist1, Lieneke Pool2, Karin Ha¨gerbrand1, William W. Agace1,2
and Aymeric Rivollier2
1 Immunology Section, Lund University, Lund, Sweden
2 Section of Immunology and Vaccinology, National Veterinary Institute, Technical University
of Denmark, Frederiksberg, Denmark
IL-18 has been implicated in inflammatory bowel disease (IBD), however its role in
the regulation of intestinal CD4+ T-cell function remains unclear. Here we show that
murine intestinal CD4+ T cells express high levels of IL-18Rα and provide evidence that
IL-18Rα expression is induced on these cells subsequent to their entry into the intesti-
nal mucosa. Using the CD45RBhi T-cell transfer colitis model, we show that IL-18Rα is
expressed on IFN-γ+, IL-17+, and IL-17+IFN-γ+ effector CD4+ T cells in the inflamed
colonic lamina propria (cLP) and mesenteric lymph node (MLN) and is required for the
optimal generation and/or maintenance of IFN-γ-producing cells in the cLP. In the steady
state and during colitis, TCR-independent cytokine-induced IFN-γ and IL-17 production
by intestinal CD4+ T cells was largely IL-18Rα−dependent. Despite these findings how-
ever, IL-18Rα−deficient CD4+ T cells induced comparable intestinal pathology to WT
CD4+ T cells. These findings suggest that IL-18-dependent cytokine induced activation of
CD4+ T cells is not critical for the development of T-cell-mediated colitis.
Keywords: IFN-γ  IL-18 receptor signaling  Innate responsiveness  T-cell transfer colitis
 Additional supporting information may be found in the online version of this article at thepublisher’s web-site
Introduction
IL-18 is a member of the IL-1 cytokine superfamily produced pri-
marily by macrophages, dendritic cells, and intestinal epithelial
cells under homeostatic conditions [1, 2]. It is produced as an
inactive 24 kDa precursor (pro-IL-18) and processing to its 18 kDa
bioactive form requires inflammasome activation and the prote-
olytic activity of caspase-1 [3], or alternative processing pathways,
notably involving proteinase-3 [4]. The IL-18 receptor (IL-18R)
is composed of two subunits, IL-18 receptor alpha (IL-18Rα)
Correspondence: Dr. Aymeric Rivollier
e-mail: ayri@vet.dtu.dk
and IL-18Rβ (also known as IL-18R accessory protein IL-18Rap),
both of which consist of three extracellular immunoglobulin-like
domains and one intracellular Toll/IL-1 receptor (TIR) domain.
Ligand binding triggers receptor heterodimerization [5] and ini-
tiates downstream signaling events via the two TIR domains [6],
which recruit MyD88 and signal through IL-1R-associated kinases
(IRAK) to initiate p38MAPK andNF-κB-mediated responses [3, 7].
IL-18 expression is upregulated in a range of inflammatory and
autoimmune diseases (for recent reviews see [3, 8]), including
inflammatory bowel disease (IBD), the two major forms of which
are Crohn’s disease (CD) and ulcerative colitis (UC) [9, 10]. IL-18
expression is notably increased in mucosal biopsies of IBD patients
compared with those of control patients, but also in inflamed ver-
sus noninflamed intestinal tissues of IBD patients [9, 10]. The
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predominant source of IL-18 in IBD is thought to be intestinal
epithelial cells, however in CD patients during the late and most
severe phase of the disease, lamina propria (LP) macrophages
and dendritic cells become an additional source of this cytokine
[9]. Further we have recently demonstrated high levels of IL-18
expression in lymphoid follicles in the LP of CD patients in close
association with CD4+ T cells [11].
IL-18 expression is also increased in animal models of IBD
[12–14] and, depending on the model, has been reported to have
either pro or anti-inflammatory activities [15, 16]. A possible
explanation for these results is that IL-18 may have distinct func-
tions depending on the stage of the disease, the cellular sources of
IL-18 and the presence of specific IL-18R-expressing effector cells
[9, 17–21]. Subsets of CD4+ T helper cells in both humans and
mice express IL-18Rα [11, 22, 23] and we recently demonstrated
that most CD4+ T cells in the healthy and inflamed human intes-
tine express IL-18Rα and thus represent a potentially important
IL-18-responsive population in IBD [11]. Regarding direct effects
on CD4+ T cells, IL-18 promotes both Th1 and Th2 development
[24] and synergizes with IL-12 to drive the proliferation of and
IFN-γ production by Th1 cells in the context of T cell receptor
(TCR) stimulation [7]. Interestingly in human effector/memory
CD4+ T cells, IL-18 in combination with IL-12 can induce IFN-γ
production and can synergize with IL-23 to induce potent IL-17
production from Th17-polarized effectors, independently of TCR
stimulation, a property often referred to as “innate responsiveness”
[7, 25–27]. In this regard, we recently demonstrated that IL-15 or
the TNF-like ligand 1a (TL1a), together with IL-12/IL-18, induce
the production of a wide range of cytokines in human intestinal
CD4+ T cells, in a TCR-independent but IL-18-dependent manner
[11]. The role of IL-18-dependent innate CD4+ T-cell responses in
the setting of intestinal inflammation is however unclear.
In the current study we assess the role of IL-18Rα expression
by murine CD4+ T cells in cytokine-induced cytokine production
and its contribution to driving inflammation in vivo during CD4+
T-cell-dependent colitis.
Results
Intestinal IFN-γ+, IL-17+, and Foxp3+ CD4+ T cells
express IL-18Rα
To determine which subsets of murine CD4+ T cells express IL-
18Rα and are thus potentially responsive to IL-18, cells were iso-
lated from murine MLN, spleen, small intestinal lamina propria
(siLP) and cLP and IL-18Rα expression assessed by FACS (Fig. 1).
IL-18Rα was expressed on a small proportion of total splenic and
MLN CD4+ T cells (Fig. 1A) and further sub-setting of these cells
revealed high IL-18Rα expression on 20–40% of central memory
and effector memory, but not na¨ıve, CD4+ T cells (Fig. 1B and C,
data not shown). Specificity of the IL-18Rα staining was confirmed
by the absence of staining on IL-18Rα−/- cells (Supporting Infor-
mation Fig. 1A). In contrast to MLN and spleen, a large fraction of
the steady-state cLP and siLP CD4+ T cells expressed high levels
of IL-18Rα (Fig. 1D). The majority of the intestinal CD4+ T cells
displayed an effector/memory phenotype and this was unaltered
in IL-18Rα−/− mice (Supporting Information Fig. 1B and C). Fur-
ther, all cLP CD4+ IL-18Rα+ cells exhibited an effector/memory
phenotype (Supporting Information Fig. 1D–F). The proportions
of IL-18Rα+ cells varied among cLP CD4+ T cell subsets, with
IL-18Rα expressed almost ubiquitously on IL-17+ and IFN-γ+
IL-17+ cells (>90%), on the majority of IFN-γ+ cells (70-80%)
and on approximately 60% of FoxP3+ T cells (Fig. 1E–G). Col-
lectively these results demonstrate that IL-18Rαhi CD4+ T cells
are enriched in the intestinal mucosa compared with MLN and
spleen, and that IL-18Rα expression is not restricted to a specific
functional subset of intestinal CD4+ T cells.
IL-18Rα is induced preferentially on activated OT-II
CD4+ T cells localizing to the intestinal LP
To gain further insights into the regulation of IL-18Rα expres-
sion on CD4+ T cells, na¨ıve OVA-specific OT-II cells were labeled
with violet cell tracer (VCT) and injected i.v. into congenic recip-
ients. One day later recipient mice were immunized with OVA +
R848 (oral gavage) or OVA + LPS + antiCD40 (i.p.). (Fig. 2A).
IL-18Rα expression was then assessed on responding OT-II cells 4,
7, and 12 days after immunization. While injected OT-II cells did
not express IL-18Rα (Fig. 2A), OT-II cells expressing high levels of
IL-18Rα were readily detected in the siLP but not MLN or spleen at
day 7 and 12 after oral immunization (Fig. 2B–D). Similar results
were obtained after i.p. immunization of animals with OVA +
anti-CD40 + LPS and confirmed that OT-II cells start to express
IL-18Rα relatively late after activation and primarily upon local-
ization to the intestine (Fig. 2E and F). IL-18Rα, was also detected
on a minor subset of OT-II cells in the MLN, PP, spleen suggesting
some degree of IL-18Rα upregulation in these tissues or that these
cells represent OT-II cells that have first circulated through intesti-
nal sites. Finally a significant proportion of OT-II cells also started
expressing high levels of IL-18Rα in the lungs after i.p. immuniza-
tion, but to a lesser extent compared to siLP OT-II cells (Fig. 2E
and F).Together these results suggest that IL-18Rα is induced
on CD4+ T cells subsequent to their entry into the intestinal
mucosa.
Cytokine-induced cytokine production by intestinal CD4+
T cells is diminished in IL-18Rα−/− mice
To determine whether IL-18Rα expression impacted on the num-
ber and proportion of colonic CD4+ T-cell subsets, we next com-
pared the composition of cLP CD4+ T cells in IL-18Rα−/− and WT
littermate controls (Fig. 3A). The absolute numbers of CD4+ T cells
in the cLP of IL-18Rα−/− mice did not differ from those of litter-
mate controls (Fig. 3B). Similarly, no significant differences in the
proportions of IFN-γ+, IL-17+, IFN-γ+IL-17+, or FoxP3+ cells were
observed between these mice (Fig. 3B). Consistent with our find-
ings in the human intestine [11], murine intestinal IL-18Rα+CD4+
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Figure 1. IL-18Rα on a broad range of functionally distinct intestinal lamina propria CD4+ T cells. (A, B) IL-18Rα expression on (A) CD4+ cells from
spleen and MLN and (B) CD4+TCRβ+ T-cell subsets in the spleen was measured by flow cytometry. (C) The pooled MFI of IL-18Rα expression on
the indicated CD4+TCRβ+ T-cell subsets in the spleen and MLN of steady state WT mice is also shown. Each symbol represents an individual
mouse and results are pooled from three to four independent experiments. (A and B) IL-18Rα staining (black line), isotype control (filled histogram).
(C) Results are expressed as (MFI) = (MFI of IL-18Rα expression on a given T-cell subset) - (MFI of the relevant isotype control on the same T-cell
subset). Of note, CD4+TCRβ+ and CD4+CD3+ T cells are completely overlapping populations in the MLN, spleen, siLP, and cLP. Therefore both
gating strategies have been used interchangeably in this work. (D) IL-18Rα expression on total live CD4+CD3+ intestinal LP T cells. IL-18Rα staining
(black line), isotype control (filled histogram). (E–G) Surface IL-18Rα expression on IFN-γ+, IFN-γ+IL-17A+, IL-17A+, and Foxp3+ CD4+CD3+ T cells
from SI and cLP of steady state WT mice, assessed by flow cytometry. (E) Representative gating for IFN-γ+ (dashed line), IFN-γ+IL-17A+ (black
line), IL-17A+ (grey line) cells (left). Histogram overlay of IL-18Rα expression on the subsets defined in the left panels (right). An isotype control
staining on total CD4+CD3+ T cells (filled histogram) was also included in the histograms overlay. (F) Representative FoxP3 intracellular staining
on live CD4+CD3+ T cells from the SI and cLP of steady state WT mice (left). IL-18Rα expression on the defined FoxP3+ T cells (black line) and
respective isotype control (filled histogram, right). (G) Quantification of IL-18Rα+ cells within SI (gray circles) and colon LP (black circles) IFN-γ+,
IL-17A+, IL-17A+IFN-γ+, and FoxP3+ cells defined in (E) and (F). Results are shown as mean ± (SEM) from two independent experiments; each
symbol represents results from a single mouse.
C© 2016 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim www.eji-journal.eu
1374 Petra Holmkvist et al. Eur. J. Immunol. 2016. 46: 1371–1382
A Input OT-II T cells
IL-18R
%
 o
f M
ax
0 103 104 105
1.9
0
20
40
60
80
100
day:        
analysis
i.v
oral OVA + R848
or
i.p. OVA + CD40 mAb + LPS
74-1 0 12
B C
IL
-1
8R
α
VCT
day 4
day 7
day 12
4 7 12
0
5
10
15
20
25 ns ns
ns
0
5
10
15
20
25 ns ns
ns
0
10
20
30
40 * ns
**
M
FI
IL
-
18
R
time (days)
0
2000
4000
6000 * ns
ΔM
FI
 IL
-1
8R
α
%
 fr
om
 O
T-
II 
ce
lls
MLN PP siLP
0.1 0
099.9
0 0
0.699.5
1.1 0
098.8
0
0.3199.4
0
0.399.5
0
0.293
0.6 0
3.495.9
0 0
3.697.3
17.9 0
081.1
0.2 0.2 6.8
0102 103 104 105 0102 103 104 105 0102 103 104 105
0
102
103
104
105
0102 103 104 105 0102 103 104 105 0102 103 104 105
0102 103 104 105 0102 103 104 105 0102 103 104 105
0
102
103
104
105
0
102
103
104
105
D
time (days)
MLN PP siLP
siLP
**
4 7 12 4 7 12
4 7 12
E
4 7 12
0
20
40
60
80
%
 fr
o
m
 
O
T-
II 
ce
lls
***
***
ns
4 7 12
0
20
40
60
80 ***
***
ns
4 7 120
20
40
60
80 ***
***
ns
4 7 12
0
20
40
60
80 ***
***
ns
4 7 120
20
40
60
80 **
**
ns
MLN PP siLP SPLEEN LUNG F
4 7 120
500
1000
1500
ΔM
FI
 I L
-1
8R
***
***
ns
4 7 120
500
1000
1500
ns
ns
ns
siLP LUNG
time (days) time (days)
Figure 2. IL-18Rα is induced preferentially on activated OT-II CD4+ T cells localizing to the intestinal LP. VCT-labeled naı¨ve OT-II cells were injected
i.v. into WT recipient mice subsequently immunized with OVA + R848 (oral gavage) or OVA + LPS + antiCD40 (i.p.). (A) IL-18Rα expression on input
OT-II cells and experimental workflow. Isotype control (filled histogram). (B–D) IL-18Rα expression on OT-II cells in the indicated organs at day 4,
7, and 12 after oral immunization was evaluated by flow cytometry and shown as (B) representative plots, (C) cellular percentages, and (D) IL-18Rα
MFI. (D) MFI = (MFI of IL-18Rα on IL-18Rα+ cells) - (MFI of the relevant isotype control on total donor-derived OT-II cells). (C and D). Results are
shown as mean ± SEM of data pooled from two experiments; each symbol represents a single mouse. (E-F) IL-18Rα expression by OT-II cells in the
indicated organs at day 4, 7, and 12 after i.p. immunization is shown as (E) cellular percentages and (F) MFI. Results are shown as mean ± SEM
of data pooled from two independent experiments; each symbol represents a single mouse. (D and F) MFI = (MFI of IL-18Rα on IL-18Rα+ cells) -
(MFI of the relevant isotype control on total donor-derived OT-II cells). Statistical analysis was performed using a nonparametric Student’s t-test
(*p<0.05, **p<0.01, ***p<0.001, n.s. nonsignificant).
T cells co-expressed the TL1a receptor, death receptor-3 (DR3)
(Fig. 3C). Since IL-12, TL1a, IL-15 have been shown to synergisti-
cally induce TCR-independent IL-18-dependent cytokine produc-
tion in human siLP IL-18Rα+DR3+ CD4+ T cells [11], we next
assessed the role of IL-18Rα in cytokine-induced cytokine produc-
tion by murine intestinal CD4+ T cells. SiLP and cLP CD4+ T from
IL-18Rα−/− mice orWT littermate controls were stimulated in vitro
with IL-12, IL-18, IL-15, and TL1a and their expression of IFN-γ
and IL-17 assessed after 48 h by FACS (Fig. 3D and E). IL-12/
IL-18/TL1a/IL-15 induced IFN-γ and IL-17 production in siLP and
cLP CD4+ T cells from WT mice, while little cytokine production
was observed from IL-18Rα deficient CD4+ T cells (Fig. 3D and
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Figure 3. IL-18Rα is important for
TCR-independent cytokine-induced
cytokine production by colonic
intestinal CD4+ T cells. (A) Repre-
sentative flow cytometry plots and
(B) quantification of the absolute
numbers of CD4+TCRβ+ cLP T cells
and of the percentages of IFN-γ+,
IL-17+, IFN-γ+IL-17+, and FoxP3+
subsets within these cells in
IL-18Rα−/− and WT littermate con-
trol mice. (B) Mean ± SEM of three
independent experiments, each
symbol represents a single mouse.
(C) Representative plots of IL-18Rα
and death receptor 3 (DR3) expres-
sion on colonic and SI LP CD4+CD3+
T cells. Plots are representative of
nine biological replicates pooled
from three experiments. (D–F)
Intestinal LPMCs from IL-18Rα−/−
mice and littermate controls were
cultured with IL-12, IL-18, IL-15, and
TL1a for 48 h. (D) Representative
cLP flow cytometry plots and
(E) quantification of the percentages
of IFN-γ+ and IL-17+ subsets within
CD4+TCRβ+ T cells in the cLP and the
siLP. (E) Mean ± SEM of three inde-
pendent experiments, each circle
represents cells from an individual
mouse. Statistical analysis was
performed using a nonparametric
Student’s t-test (*p<0.05, **p<0.01,
***p<0.001, n.s. nonsignificant).
E). Consistent with these findings cytokine production was largely
restricted to IL-18Rα expressing CD4+ T cells (Fig. 3F). Further,
stimulation of total cLP and siLP cells with IL-12/IL-18/TL1a/
IL-15, confirmed that IL-18Rα expression was required for opti-
mal secretion of IFN-γ, IL-17, GM-CSF, IL-13 but not IL-10 or IL-6
(Supporting Information Fig. 2A). To assess the individual con-
tribution of each cytokine in driving the TCR-independent IFN-γ
production by CD4+ T cells, purified cLP CD4+ T cells were incu-
bated with each cytokine alone or in combination (Supporting
Information Fig. 2B). While each cytokine alone induced little
IFN-γ production, addition of only IL-12 and IL-18 resulted in a
dramatic increase in IFN-γ production (Supporting Information
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Fig. 2B). In contrast to what we have previously observed with
human intestinal CD4+ LP T cells, the addition of TL1a, IL-15,
or TL1a and IL-15, to IL-12 and IL-18 did not further increase
the production of IFN-γ by these cells (Supporting Information
Fig. 2B). Previous reports have suggested that the synergy between
IL-12 and IL-18 in driving IFN-γ production may be related to
the capacity of IL-12 to upregulate IL-18Rα in mouse Th1 cells
[28, 29]. While cLP CD4+ T cells, stimulated with IL-12+IL-18 ±
IL-15+TL1a showed a trend toward enhanced IL-18Rα expression
compared with medium alone, this did not reach statistical sig-
nificance (Supporting Information Fig. 2C and D). In comparison,
expression of IL-15Rα was not regulated by addition of any of the
cytokines (Supporting Information Fig. 2C and D). Collectively
these results suggest an important role for IL-18Rα in cytokine-
induced cytokine production by intestinal LPMC and cytokine-
induced IFN-γ and IL-17 production by intestinal LP CD4+ T cells.
IL-18Rα is expressed on most intestinal CD4+T cells
during experimental colitis
To assess whether IL-18Rα is expressed on intestinal CD4+ T cells
during experimental colitis, WT CD45RBhiCD4+ T cells were
injected into RAG−/− recipients and IL-18Rα expression on donor
CD4+ T cells was assessed in the MLN and cLP after 6–7 weeks
(Fig. 4A), a time point where mice had developed active colitis.
IL-18Rα was expressed at high levels on the majority of CD4+
T cells in the cLP and MLN (Fig. 4A). Furthermore IL-18Rα was
expressed on almost all effector CD4+ T cells, irrespective of
whether they produced IFN-γ, IL-17, or both cytokines (Fig. 4B
and C). Similarly to the steady-state condition, 50–60% of cLP
and MLN FoxP3+ Treg cells expressed IL-18Rα during colitis. Of
note, the majority of MLN, cLP and spleen CD4+ T cells also
expressed IL-18Rα in RAG –/- recipients of na¨ıve CD45RBhi T cells
and WT CD45RBlo T cells (which do not develop inflammation)
(data not shown), indicating that the high proportions of IL-18Rα-
expressing T cells was a result of the RAG−/- lymphopenic and not
of the chronic inflammatory environment.
IL-18Rα signaling in CD4+ T cells is dispensable for
the induction of T-cell-mediated colitis
Given the fact that IL-18Rα was expressed on the vast majority of
IFN-γ- and IL-17-producing CD4+ T cells in the MLN and cLP of
colitic mice (Fig. 4B and C) and that these cells are thought to be
directly involved in driving intestinal pathology in this model [30],
we sought to evaluate the impact of an IL-18Rα deficiency specif-
ically in CD4+ T cells on colitis development. CD45RBhi CD4+
T cells from IL18Rα−/- mice or WT littermate controls were thus
transferred into RAG−/− mice. Six to seven weeks after transfer,
recipients of IL-18Rα−/− or WT T cells displayed similar severe
colonic inflammation, as assessed by histological score (Fig. 4D
and E). In addition, the total numbers of CD4+ T cells accumulat-
ing in the MLN and cLP of colitic mice were similar between both
groups of recipient mice (Fig. 4F). Quantitative PCR analyses on
total colon tissue showed that the absence of IL-18Rα signaling in
CD4+ T cells also had no impact on the production of IL-12 and
IL-23 mRNA in the cLP (data not shown). FACS analyses revealed
that IL-18Rα deficiency had no impact on the Th1/Th17/Treg
cell balance in the MLN, 6-7 weeks after transfer (Fig. 4G–J). In
contrast, the cLP of IL-18Rα−/- CD4+ T-cell recipients contained
significantly decreased numbers of IFN-γ+ and IFN-γ+IL-17+ but
not IL-17+ or FoxP3+ cells, compared to recipient of WT CD4+
T cells (Fig. 4 G–J). Collectively these results demonstrate that
although IL-18Rα signaling in CD4+ T cells is required for the
optimal generation of Th1 cells, it is dispensable for colitogenic
function of CD4+ T cells in this model.
IL-18Rα is required for cytokine-induced cytokine
production by colonic intestinal CD4+ T cells during
inflammation
Given that RAG−/− recipients of IL-18Rα–/– and WT CD4+ T cells
developed similar levels of intestinal inflammation we sought
to determine whether intestinal CD4+ T cells maintained their
innate-like properties during inflammation and whether this
cytokine production remained IL-18Rα dependant. WT CD4+
T cells from colitic mice maintained their ability to produce
cytokines after stimulation with IL-12/IL-18/IL-15/TL1a com-
pared with medium alone and these responses remained absent in
IL-18Rα−/− CD4+ T cells (Fig. 5). Collectively these results suggest
that the innate-like cytokine response of intestinal CD4+ T cells
remains IL-18 dependent during colitis, however this property of
CD4+ T cells appears dispensable for the development of intestinal
inflammation in the T-cell transfer colitis model.
Discussion
We recently reported that a large proportion of CD4+ T cells
from the healthy and inflamed human intestine expresses
IL-18Rα and a key role for IL-18 in TCR-independent cytokine
induced pro-inflammatory cytokine production by these cells [11].
The purpose of the current study was thus to evaluate whether
this TCR-independent, IL-18-dependent, innate responsiveness of
mucosal memory CD4+ T cells contributed to the pathogenesis
of IBD. While murine intestinal CD4+ T cells displayed simi-
lar TCR-independent IL-18-dependent innate functionality under
both homeostatic and inflammatory conditions, we demonstrate
that this functionality is dispensable for T-cell-induced colitis
development. IL-18-driven TCR-independent IFN-γ production by
CD4+ T cells was recently reported to be an important compo-
nent of the in vivo bactericidal function of Th1 cells during acute
Salmonella or Chlamydia infections [31, 32], The T-cell transfer
colitis model, in contrast, is a chronic model in which the immune
system is continually stimulated by commensal bacteria breaching
the intestinal epithelium [33]. It is therefore possible that in this
model such chronic antigen exposure compensates for the defect in
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dent’s t-test (*p<0.05, **p<0.01, ***p<0.001, n.s. nonsignificant).
IL-18-dependent innate cytokine response of CD4+ T cells. In this
regard it will be of interest in future studies to assess the role
of IL-18Rα-dependent innate responses of CD4+ T cells in more
acute models of mucosal inflammation and infection.
Similar to our current findings, Harrison et al. demonstrated
that IL-18Rα expression by CD4+ T cells is not required for col-
itis induction [34]. These authors however did not assess alter-
ations in proportions of CD4+ effector cell subsets in the context
of IL-18Rα deficiency and colitis. Here we show that cLP CD4+
IL-18Rα−/− T cells exhibit a marked reduction in IFN-γ producing
Th1 cells during colitis. One possible mechanism underlying this
finding is IL-18s ability to synergize with IL-12 to promote the pro-
liferation and IFN-γ production by Th1 cells in the context of TCR
stimulation [7]. In addition, as we show here, IL-18 together with
IL-12, in a TCR independent manner, dramatically enhances IFN-γ
production by intestinal CD4+ T cells. Thus IL-18 may, in a TCR-
independent manner, promote the expansion and/or maintenance
of Th1 cells in the context of colitis.
The mechanism by which IL-12 and IL-18 synergize to promote
CD4+ T cell functionality has been proposed to involve the recip-
rocal upregulation of IL-18Rα and IL-12Rβ2 by IL-12 and IL-18 sig-
naling respectively in committed Th1 cells [28, 29, 35], as well as
synergistic intracellular signaling pathways directly activating the
IFN-γ promoter [7, 36]. In addition, IL-18 has been shown to stabi-
lize IFN-γ mRNA through the activation of MAPK p38 [37] and to
increase Th1 cell proliferation by stimulating their production of
IL-2 [38]. Finally Yang et al. recently reported TCR-independent
IL-12 and IL-18 synergy to be dependent on IL-18-induced synthe-
sis of GADD45β (MyD118, related member of a family of proteins
that activateMAPK kinase kinases), whichmaintained a prolonged
activation of p38 MAPK [39]. The prolonged p38 MAPK activation
is a requirement for cytokine-induced but not in TCR-induced pro-
longed IFN-γ transcription [39]. In the current study, we found
that cLP CD4+ T cells incubated with IL-12 and IL-18 or IL-12/
IL-18/IL-15 and TL1a lead to a slight increase in IL-18Rα expres-
sion compared to medium alone, although changes were not sig-
nificant. Further our attempts to assess p38MAPK phosphorylation
in cytokine-stimulated cLP CD4+ were highly variable and incon-
clusive, potentially as a result of the lengthy isolation procedure
of these cells. Further studies are thus required to explore the
mechanisms underlying the synergistic effects of IL-12 and IL-18
on TCR-dependent and independent cLP CD4+ T-cell functionality
in a steady state and during colitis.
The similar degree of colitis development, despite marked
reduction in Th1 cell numbers, raises the questions of the role
of Th1 cells in the transfer colitis model. It is possible, that
the remaining IFN-γ+ cells in RAG−/− recipients of IL-18Rα−/−
T cells are sufficient to promote intestinal pathology or that,
IL-17-producing CD4+ T cells in this context play a more promi-
nent role. While initial assessment of the role of Th1 cells in this
model of colitis have provided conflicting data [40, 41], more
recent studies suggest that “classical” Th1 cells are dispensable for
the development of intestinal pathology and that Th17 cells were
more potent at driving disease, notably by generating colitogenic
IFN-γ+ “alternative” Th1cells”, via IFN-γ+IL-17+ intermediaries,
in a T-bet and STAT-4-dependent manner [42–44]. In our col-
itis experiments, IL-18R signaling deficiency had no impact on
the numbers of IL-17+ cells, but reduced the numbers of both
IFN-γ+IL-17+ and IFN-γ+ cells, suggesting that IL-18 could also
be implicated in the generation of “alternative Th1cells” in this
context, although this did not change the final colitis outcome.
Finally Harrison et al. recently demonstrated that IL-18R signal-
ing is required for the optimal suppressive function of FoxP3+
Treg cells and that IL-18R signaling promotes the expression of
key FoxP3+ Treg cell effector molecules [34]. Thus, while we
found that IL-18R-signaling was not required for the generation
of intestinal FoxP3+ Treg cells under steady state or inflamma-
tory conditions, reduced functionality of IL-18Rα−/− FoxP3+ Tregs
could partially underlie IL-18Rα−/− CD4+ T cell mediated coli-
tis. The mechanisms underlying IL-18Rα−/−CD4+ T cell-mediated
colitis and whether they are the same or distinct from that of WT
CD4+ T-cell-driven colitis awaits further study.
A surprising finding from the current study was that
IL-18Rα-/- and WT littermate control animals exhibited similar
numbers and frequencies of intestinal Th1, Th17, and FoxP3+
T cells in the steady state. These results contrast markedly with
the report from Harrison et al. suggesting that intestinal epithelial
cell-derived IL-18 acted directly on colonic IL-18Rα+CD4+ T cells
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to limit their differentiation into Th17 cells under steady state
conditions and that IL-1 receptor (IL-1R1) or MyD88 expression
by CD4+ T cells was required for IL-18-mediated control of Th17
differentiation [34]. Quantitative PCR analyses demonstrated that
our IL-18Rα−/− mice and littermate controls contained similar lev-
els of segmented filamentous bacteria (SFB, data not shown).
Therefore the lack of differences in the numbers of intestinal
IL-17+ cells in our IL-18Rα−/− mice compared to control WT mice
cannot be explained by an absence of the Th17-inducing SFB in
our colony versus the mouse colony analyzed by Harrison et al. It
remains however possible that the differential effects of IL-18Rα
deficiency between the two studies at least partially depends on
quantitative or qualitative differences in other colonic commensal
bacteria. Relevant to that point, the IL-18Rα−/− and WT animals
used in the study by Harrison et al. were co-housed, while our
animals were littermates. We hypothesize that yet to be identified
commensals present in our animal facility are stimulating Th17
differentiation via pathways that cannot be blocked by IL-18Rα
signaling.
Regarding the regulation of IL-18Rα expression, our results
suggest that IL-18Rα induction on CD4+ T cells is not simply a
consequence of late stage T activation but rather of the environ-
ment to which activated T cells localize. High IL-18Rα expres-
sion was detected primarily on CD4+ T cells subsequent to their
localization to the intestine, irrespective of the route of immu-
nization, indicating that the intestinal environment preferentially
retains IL-18Rαhi cells, or promotes the expression of IL-18Rα
expression and/or preferential survival of these T cells. Interest-
ingly, the significant proportion of IL-18Rαhi OT-II cells detected at
another mucosal site (lungs) after i.p. (Fig. 2E and F) but not oral
(data not shown) immunization, suggests that factors driving high
IL-18Rα expression could also be present at multiple mucosal sites.
Further studies are required to define the mechanism underlying
the preferential accumulation of IL-18Rα+ T cells in the intestine
and putative regulators of IL-18Rα expression.
In conclusion, we demonstrate a role for IL-18Rα signaling in
CD4+ T cells in the generation of IFN-γ producing CD4+ T cells
during colitis and in cytokine driven innate CD4+ T cell responses
in both the steady state and inflammatory setting. Despite these
findings we show that IL-18Rα signaling in CD4+ T cells is dis-
pensable for the induction of T-cell mediated colitis.
Material and methods
Mice
C57BL/6mice were purchased from Taconic Farms (Germantown,
NY). B6.Cg- Tg(TcraTcrb)425Cbn/J (OT-II), IL-18Ra−/− and Rag-
1−/− mice were purchased from Jackson Laboratory (Bar Harbor,
ME, USA). All mice were maintained at the Biomedical Center,
Lund or Clinical Research Center, Malmo¨. Animal experiments
were performed in accordance with the Lund/Malmo¨ Animal
Ethics Committee in Lund, Sweden.
Reagents and cytokines
RPMI-1640, PBS, Hank’s Balanced Salt Solution (HBSS), fetal
calf serum (FCS), hepes buffer, EDTA, sodium pyruvate,
β-mercaptoethanol, penicillin, streptomycin, and gentamycinwere
from Invitrogen (Carlsbad, CA). Brefeldin A, PMA, OVA grade V
and VI, collagenase IV, DTT and LPS were from Sigma-Aldrich (St.
Louis, MO, USA). Ionomycin was from Calbiochem (San Diego,
CA, USA). DNase I and Liberase TMwere from Roche (Mannheim,
Germany). Violet cell tracer proliferation kit and live/dead fixable
dead cell stain kits were from Molecular Probes Inc. (Eugene,
OR, USA). Recombinant mouse (rm) IL-12, IL-15, IL-18 and TL1a
were from R&D systems (Minneapolis, MN, USA). R848 was from
InvivoGen (Toulouse, France). Purified anti-CD40 (FGK4.5) mAb
was from BioXCell (West Lebanon, NH, USA).
Flow cytometry and antibodies
Flow cytometry was performed as previously described [45]. For
intracellular cytokine and FoxP3 staining cells were fixed and
permeabilized with “Foxp3 staining buffer set” from eBioscience
(San Diego, CA, USA). Cells were analyzed on an LSR II (BD Bio-
sciences, San Jose, CA, USA). Flow cytometry data were analyzed
using FlowJo software (TreeStar, Inc., Ashland, OR, USA).
Antibodies: anti-CD3 (17A2), -IL-18Rα (BG/IL18RA), rat IgG1
isotype control (RTK2071), -IFN-γ (XMG1.2), -IL-17A (TC11-
18H10.1), -GM-CSF (MP1-22E9), and -CD25 (PC61) were from
Biolegend (San Diego, CA, USA). Anti-CD4 (RM4-5 or GK1.5),
-CD45RB (C363.16A), -CD45.2 (104), -TNF-α (MP6-XT22), -
Foxp3 (FJK-16s), -CD62L (MEL-14) were from eBioscience. Anti-
CD3 (145-2C11), -CD44 (IM7), -CD45.1 (A20) and PE-CF594-
streptavidin were from BD biosciences. Anti-DR3 (goat polyclonal)
and -IL-15Rα (888220) were from R&D systems.
Cell isolation
Cell suspensions from MLN, spleen, siLP, and cLP were prepared
as described previously [46], replacing collagenase VIII with Lib-
erase TM (0.2-0.3WunchU/mL). For isolation of cLP CD4+ T cells,
cell suspensions were further enriched on 40/70 Percoll gradi-
ents (Amersham Pharmacia Biotech, Sweden), MACS-enriched
using anti-CD4microbeads and autoMACS-pro separator (Miltenyi
biotec, Germany).
Adoptive transfer experiments
Na¨ıve CD4+ T cells were isolated from OT-II mice using the
EasySepTM Mouse Na¨ıve CD4+ T Cell Isolation Kit (Stemcell Tech-
nologies, Vancouver, Canada) and labeled with cell trace violet
cell proliferation kit (Molecular Probes) according to manufac-
turer’s instructions. C57BL/6 mice were injected i.v. with 0.5 ×
106 OT-II.CD45.1.CD45.2 cells and immunized one day later with
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OVA grade V (50 mg/mL) and R848 (20 μg/mL) by oral gavage in
200 μL of PBS or with OVA grade VI (2.5 mg/mL), anti-CD40 mAb
(125 μg/mL), and LPS (100 μg/mL) by intra-peritoneal injection
in 200 μL of PBS.
Cultures and cytokine measurements
Intestinal LPMC (4 × 106 cells in 0.5 mL/well) or MACS-enriched
CD4+ T cells (2 × 105 cells in 200 μL/well) were cultured in com-
plete RPMImedium supplemented with IL-12 (2 ng/mL) and IL-18
(50 ng/mL), or IL-12/IL-18 together with IL-15 (25 ng/mL), and
TL1a (100 ng/mL). After 48h, cytokine levels in culture super-
natants were determined by Bio-Plex technology (Bio-rad, Her-
cules, CA, USA) or using cytometric bead array (CBA) flex set
kits (BD Biosciences) or in CD4+ T cells by intracellular cytokine
staining (brefeldin A (10 μg/mL) was included during the last
3 h of culture). To determine the proportion of Th1/Th17 cells
within intestinal CD4+ T cells, LPMC were stimulated for 4 h with
PMA (50 ng/mL) and ionomycin (500 ng/mL) in the presence of
brefeldin A prior to intracellular cytokine analysis.
CD45RBhigh transfer model of colitis
Six- to eight-week-old, sex matched RAG-1−/− mice were
injected i.p. with FACS-sorted CD4+CD25−CD45RBhi T cells
(3 × 105cells/mouse) from IL-18Rα−/− mice or WT littermates
controls, as previously described [47]. Mice were sacrificed after
6 to 7 weeks and MLN and colon taken for analysis. Samples of
proximal, mid, and distal colon were collected, fixed in formalin,
embedded in paraffin, before preparing cross-sections and further
staining with hematoxylin and eosin. The degree of inflamma-
tion on microscopic colon section was graded in a blinded fashion
to avoid bias, according to a previously described scoring system
[48]. Each sample was graded semi-quantitatively from zero to
three for four criteria: (i) crypt length, degree of epithelial hyper-
plasia, and goblet cell depletion; (ii) leukocyte infiltration in the
lamina propria; (iii) area of tissue affected; and (iv) presence
of markers of severe inflammation such as crypt abscesses, sub-
mucosal inflammation, and ulcers. Scores for each criterion were
added to give an overall inflammation score for each sample of
0–12. Scores from proximal, mid, and distal colon were averaged
to obtain inflammation scores for the colon.
Statistical analysis
All single column comparisons were performed using nonpara-
metric Student’s t-test and all multiple column analyses were per-
formed using ANOVA followed by “Bonferroni’s Multiple Compar-
ison Test” (*p<0.05, **p<0.01, ***p<0.001). Statistical analysis
was performed using GraphPad Prism software (GraphPad, La
Jolla, CA, USA).
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